SCHEMBL3660489

O=C(NS(=O)(=O)c1ccc(NC(CCN2C[C@H]3C[C@H]2CO3)CSc2ccccc2)c(S(=O)(=O)C(F)(F)Cl)c1)c1ccc(N2CCN(CC3=C(c4ccc(Cl)cc4)CCCC3)CC2)cc1

nearest known ligand 0.71

Predicted protein targets (top 8)

	gene	UniProt	supporting neighbours	confidence
▸	BCL2L1	Q07817	18/20	0.71

▸	BCL2	P10415	17/20	0.71

▸	BCL2L2	Q92843	2/20	0.71

▸	BCL2L11	O43521	1/20	0.65

▸	CYP2C9	P11712	1/20	0.65

▸	MCL1	Q07820	1/20	0.65

▸	ASPH	Q12797	1/20	0.65

▸	BAD	Q92934	1/20	0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL19419612	1.00	BCL2L1 (0.71)	BCL2L1BCL2BCL2L2BCL2L11CYP2C9
SCHEMBL2080825	1.00	BCL2L1 (0.71)	BCL2L1BCL2BCL2L2BCL2L11CYP2C9
SCHEMBL2079676	0.99	BCL2L1 (0.70)	BCL2L1BCL2BCL2L2BCL2L11CYP2C9
SCHEMBL2081114	0.96	BCL2L1 (0.70)	BCL2L1BCL2BCL2L2BCL2L11CYP2C9
SCHEMBL19419607	0.96	BCL2L1 (0.69)	BCL2L1BCL2BCL2L2BCL2L11CYP2C9
SCHEMBL2080773	0.96	BCL2L1 (0.69)	BCL2L1BCL2BCL2L2BCL2L11CYP2C9
SCHEMBL4829589	0.96	BCL2L1 (0.69)	BCL2L1BCL2BCL2L2BCL2L11CYP2C9
SCHEMBL1958008	0.92	BCL2L1 (0.84)	BCL2L1BCL2BCL2L2BCL2L11CYP2C9
SCHEMBL19419613	0.92	BCL2L1 (0.84)	BCL2L1BCL2BCL2L2BCL2L11CYP2C9
SCHEMBL19424184	0.92	BCL2L1 (0.84)	BCL2L1BCL2BCL2L2BCL2L11CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
EP-2231159-A1	METHOD OF TREATING ARTHRITIS	Abbott Laboratories (US)	2010-09-29	—	—	EP	disclosed
WO-2009064938-A1	METHOD OF TREATING ARTHRITIS	ABBOTT LABORATORIES (US)	2009-05-22	—	—	WO	disclosed